Paul A. Northcott

Paul A. Northcott is a Professor at the German Cancer Research Center (DKFZ) specializing in pediatric neuro-oncology, with a particular focus on medulloblastoma, the most common malignant brain tumor in children. His work bridges molecular oncology, cancer genetics, and developmental biology to understand the fundamental mechanisms driving pediatric brain cancer.

Dr. Northcott's research program investigates:

• Molecular mechanisms of Sonic Hedgehog (SHH) medulloblastoma pathogenesis
• Genetic predisposition factors including ELP1 and ZIC1
• Cellular origins of different medulloblastoma molecular subgroups
• Identification of novel therapeutic targets and precision medicine approaches

His recent work has made significant contributions to understanding ELP1-associated medulloblastoma, demonstrating how germline ELP1 variants predispose to SHH medulloblastoma and identifying MDM2 inhibition as a potential therapeutic strategy. He has also revealed the context-dependent role of ZIC1 as both tumor suppressor and potential oncogene depending on medulloblastoma subgroup.

Dr. Northcott contributes to major collaborative initiatives including the Virtual Child project, which aims to create computational models of normal and cancerous human development. His work has been published in leading journals including Nature Genetics, Cancer Cell, and Neuro-Oncology, reflecting his significant impact on the field of pediatric neuro-oncology.